C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2001
11/08/2001	WO2001038564A3 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
11/08/2001	WO2001038348A3 G-protein coupled receptor htogh35
11/08/2001	WO2001037780A8 Urotensin-ii analogs
11/08/2001	WO2001036630A3 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same
11/08/2001	WO2001036489A3 Erythropoietin forms with improved properties
11/08/2001	WO2001032904A3 Method for enhancing secretion of beta-lactam compounds
11/08/2001	WO2001032697A3 Virulence genes and proteins from brucella melitensis, and their use
11/08/2001	WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
11/08/2001	WO2001032128A3 Human chemokine beta-13
11/08/2001	WO2001030810A3 Relaxase and other vir proteins as targets for treatment of helicobacter pylori infection and as dna transfer system to mammalian cells
11/08/2001	WO2001029068A3 A eag gene encoding for a potassium channel
11/08/2001	WO2001025455A3 Promoter for regulating expression of foreign genes
11/08/2001	WO2001023553A3 Metastasis-associated antigen c4.4a
11/08/2001	WO2001023414A3 Immunologically significant herpes simplex virus antigens
11/08/2001	WO2001019958A3 Stabilized soluble glycoprotein trimers
11/08/2001	WO2001018037A3 A p53-induced protein with a death domain that can promote apoptosis
11/08/2001	WO2001018035A3 Muc-1 derived peptides
11/08/2001	WO2001002551A3 Virus like particles, preparation and use in screening and functional genomics
11/08/2001	WO2000069897A3 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes
11/08/2001	WO2000061194A3 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
11/08/2001	WO2000060359A9 Interactions of ku polypeptides
11/08/2001	WO2000044767A3 Method for drying protein crystals
11/08/2001	WO2000042221A9 Method for the affinity isolation of newly synthesized rna
11/08/2001	WO2000006713A8 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin
11/08/2001	US20010039670 Oxidative stress resistance gene
11/08/2001	US20010039669 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1
11/08/2001	US20010039666 Non-human mammalian model for atherosclerosis and methods for screening agents for use in the treatment of atherosclerosis
11/08/2001	US20010039480 Apparatus and method for automated protein design
11/08/2001	US20010039335 Genetic engineering
11/08/2001	US20010039261 Administration of polypeptide growth factors following central nervous system ischemia or trauma
11/08/2001	US20010039260 Pulmonary insulin crystals
11/08/2001	US20010039253 Exhibit alterations in at least one of the following properties relative to parent alpha-amylase: improved pH stability at pH 8-10.5, improved calcium ion stability at pH 8-10.5, increased specific activity at 10-60 degrees C
11/08/2001	US20010039052 Surface antigen expression allows for identification and selection of genetically modified cells; gene therapy
11/08/2001	US20010039051 Utlizing the Varicella-Zoster virus protein's ability to enter and exit eukaryotic cells for drug or secreting agent delivery
11/08/2001	US20010039049 Inducing multipotent neural stem cells to proliferate in the presence of the title hormone to produce neuronal progenitor cells and allowing them to differentiate into neurons Parkinson's and Alzheimer diseases; transplantation
11/08/2001	US20010039048 Recombinant adenovirus and its use for the prevention and treatment of fibrotic disease
11/08/2001	US20010039046 Genetically engineered adenovirus comprising a genome whose E1 region is deactivated, whose organization is modified and the recombination of which with the genome of the producing line leads to the new viral vectors; gene therapy
11/08/2001	US20010039044 Transfecting cells with a recombinant adeno-associated virus (AAV) which can be package into infectious AAV virions, a helper AAV vector essential for replication and packaging and a productive vector which cannot be packaged into the virion
11/08/2001	US20010039038 Novel glucosaminidase
11/08/2001	US20010039037 Novel polypeptide
11/08/2001	US20010039036 Cloning and recombinant production of receptor(s) of the activin/TGF-beta superfamily
11/08/2001	US20010039011 Complexing; biosynthesis
11/08/2001	US20010039008 Immunofluorescence
11/08/2001	US20010038843 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies
11/08/2001	US20010038837 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart
11/08/2001	DE10021475A1 New opioid-type receptor-1 gene, OTR1, useful for diagnosis and treatment of OTR1-related diseases
11/08/2001	DE10021474A1 New monoamine receptor-1 gene, MAR1, useful for diagnosis and treatment of MAR1-related diseases
11/08/2001	DE10019289A1 Method for detecting cocoa components in cocoa products, useful e.g. for quality control, comprises amplifying a new husk-specific DNA
11/08/2001	CA2750984A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2420287A1 Anthrax specific antibodies
11/08/2001	CA2416725A1 Immunizing against hiv infection
11/08/2001	CA2414775A1 A method and device for improving protein stability and solubility
11/08/2001	CA2414296A1 Anti-inflammatory compounds and uses thereof
11/08/2001	CA2414290A1 Anti-inflammatory compounds and uses thereof
11/08/2001	CA2413265A1 Porcine adenovirus type 5 vector and vaccine
11/08/2001	CA2409219A1 Cellular regulators of infectious agents and methods of use
11/08/2001	CA2408073A1 Nucleic acids encoding a novel regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	CA2408003A1 Gamma secretase substrates and in vitro assays
11/08/2001	CA2407970A1 A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof
11/08/2001	CA2407959A1 Human wingless-like gene
11/08/2001	CA2407956A1 Modified peptides as therapeutic agents
11/08/2001	CA2407946A1 Ehrlichia chaffeensis 28 kda outer membrane protein multigene family
11/08/2001	CA2407945A1 Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same
11/08/2001	CA2407893A1 New gtpase-activating protein 1
11/08/2001	CA2407887A1 Natrium-calcium exchanger protein
11/08/2001	CA2407740A1 P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
11/08/2001	CA2407738A1 Anti-freeze proteins, their production and use
11/08/2001	CA2407737A1 Regulatory nucleic acid for the abc1 gene, molecules modifying its activity and therapeutic uses
11/08/2001	CA2407695A1 Methods for binding an exogenous molecule to cellular chromatin
11/08/2001	CA2407656A1 Myocardial cell proliferation-associated genes
11/08/2001	CA2407603A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2407460A1 Targeted modification of chromatin structure
11/08/2001	CA2407443A1 Compounds and methods for the treatment and prevention of bacterial infection
11/08/2001	CA2407435A1 Rna metabolism proteins
11/08/2001	CA2407426A1 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	CA2407399A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/08/2001	CA2407219A1 Pain signaling molecules
11/08/2001	CA2407068A1 Antigenic peptide fragments of vapa protein, and uses thereof
11/08/2001	CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	CA2406746A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	CA2406621A1 Protein variants having modified immunogenicity
11/08/2001	CA2403901A1 29 human secreted proteins
11/08/2001	CA2400755A1 Improved e. coli extract for protein synthesis
11/08/2001	CA2346649A1 Separation of antithrombin iii variants by cyclodextrin-modified micellar electronic chromatography
11/07/2001	EP1152243A1 DIagnosis of Sjögren's syndrome, systemic lupus erythematosis, and scleroderma via detection of anti-retroviral antibodies
11/07/2001	EP1152060A1 5T4 tumour-associated antigen for use in tumour immunotherapy
11/07/2001	EP1152059A1 Novel cytokine recfptor-like protein
11/07/2001	EP1152012A1 Tuberculosis vaccine and peptides
11/07/2001	EP1152011A1 Peptides inhibiting vascular endothelial cell migration
11/07/2001	EP1151307A1 Methods for differentiating and monitoring parathyroid and bone status related diseases
11/07/2001	EP1151304A2 METHOD OF IDENTIFYING N-TERMINAL proBNP
11/07/2001	EP1151299A1 Method of site specific labeling of proteins and uses therefor
11/07/2001	EP1151143A1 Selection of proteins using rna-protein fusions
11/07/2001	EP1151137A1 Modulator of inflammation
11/07/2001	EP1151122A1 Latency-associated regulatory region from herpesvirus saimiri (hvs)
11/07/2001	EP1151118A1 Recombinant expression of heterologous nucleic acids in protozoa
11/07/2001	EP1151116A1 Collagen-binding physiologically active polypeptide
11/07/2001	EP1151112A1 Heat-inducible promoter
11/07/2001	EP1151108A1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus
11/07/2001	EP1151107A1 Basb059 polypeptides from neisseria meningitidis

1 ... 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 ... 2916